We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Boehringer Ingelheim to Expand Drug Discovery Aggrement with Graffinity

News   Dec 14, 2006

 
Boehringer Ingelheim to Expand Drug Discovery Aggrement with Graffinity
 
 
Advertisement
 

RELATED ARTICLES

Collaborations Aim to Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

News

Thermo Fisher Scientific announced agreements with AstraZeneca and the University of Nebraska Medical Center that will showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis.

READ MORE

Drug Molecules Developed To Combat Deadly Drug-Resistant Enterococcus

News

Purdue University researchers have developed small molecules to combat deadly, drug-resistant enterococcus.

READ MORE

Minimizing the Loss of Valuable Samples

News

A major collaborative effort has resulted in a significant technical advance in X-ray crystallographic sample strategies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE